drugset / Trial / NCT02198859

Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer

NCT02198859

Phase 1 Completed 11 enrolled University of Kansas Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Laboratory testing has suggested that lithium may decrease the incidence of certain types of cancer, including prostate cancer. Additional research has suggested that lithium decreases prostate cancer tumor size over time. This study will investigate the effect of lithium on men with prostate cancer.

Timeline

Start
2014-04
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown 600 mg Oral
Subject Lithium Carbonate Unknown 900 mg Oral
Subject Lithium Carbonate Unknown 1200 mg Oral

Indications